Anticoagulation in AF with Cirrhosis, Trends in Anticoagulation for Acute PE, Beta Blockers for Acute MI with Normal EF, Finerenone for HFpEF, Continuous vs Intermittent Infusion for Antibiotics, Cefepime vs Piperacillin-Tazobactam for Sepsis
Last Week in Medicine
00:00
Insights from the ACORN Trial: Antibiotic Efficacy and Neurological Risks
This chapter explores the key findings of the ACORN trial involving 2,500 patients, comparing VanXosin and Vanke Dosen in terms of mortality and acute kidney injury. It also discusses concerns related to cefepime, including its association with neurological dysfunction and personal accounts of its severe side effects.
Play episode from 48:11
Transcript
